This is a preview of subscription content, log in via an institution to check access.
References
Schmidt J, Warrington KJ. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management. Drugs Aging 2011; 28(8): 651–6
Weyand CM, Younge BR, Goronzy JJ. IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol 2011 Jan; 23(1): 43–9
Moller DR, Wysocka M, Greenlee BM, et al. Inhibition of human interleukin-12 production by pentoxifylline. Immunology 1997 Jun; 91(2): 197–203
Samardzic T, Jankovic V, Stosic-Grujicic S, et al. Pentoxifylline inhibits the synthesis and IFN-gamma-inducing activity of IL-18. Clin Exp Immunol 2001 May; 124(2): 274–81
Acknowledgements
No sources of funding were used to assist in the preparation of this letter. The author has no conflicts of interest that are potentially relevant to the content of this letter.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fernández-Fernández, F.J. Might Pentoxifylline Have a Role as Adjuvant Therapy for Patients with Giant Cell Arteritis?. Drugs Aging 28, 847 (2011). https://doi.org/10.2165/11596480-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11596480-000000000-00000